1. Skip to navigation
  2. Skip to content

Biomedical Polymers and Compounds™

Foster Delivery Science To Build Facility For Manufacturing Drug Delivery Polymers

absorption time of bioresorbable materials

Foster Delivery Science, a business unit of Foster Corporation, has broken ground on a new facility to support increased demand for manufacturing drug delivery and implant polymer blends. The facility is expected to be completed by May 1, 2015 at which time it will be registered with the Food and Drug Administration (FDA) to allow for processing active pharmaceutical ingredients (APIs).

Foster’s new 32,000 square foot (2,973 sq. meters) facility will be dedicated to HME processing of highly regulated materials and operate according to the controlled Good Manufacturing Practice (cGMP) regulations designated by the FDA. These materials are used for improving bioavailability and release rates of oral dose pharmaceuticals, as well as local delivery of APIs in implantable devices.

Read more...

  1. Skip to navigation
  2. Skip to content
  3. Back to top